HDAI is Putting AI to Work, Today

By Arielle Rogg, staff writer 

As healthcare spending in the US is expected to reach $8 trillion by 2032, and with Medicare and Medicaid representinghalf of that spending, integrating AI in healthcare to align resources and identify the right patient populations is necessary for healthcare organizations to succeed. Enter HDAI – a healthcare and data analytics trailblazer with actionable AI tools that are shifting the way high-performance healthcare organizations operate while improving the provider and patient experience.  

Hospice Risk

Harnessing Two Decades of R&D 

HDAI’s journey has been marked by over two decades of dedication to research and development, culminating in the creation of a robust predictive technology platform. The company leverages privileged live access to the nation’s largest longitudinal dataset, encompassing a staggering 100 million patients and 0.5 trillion records. This wealth of data forms the foundation for HDAI’s comprehensive array of predictive models and their unique analytical approach to measuring performance. 

Bridging the Analytical-Clinical Gap 

HDAI’s enterprise platform, HealthVisionTM, seamlessly integrates with a client’s Electronic Health Record (EHR) and thus facilitates real-time support of clinical decision-making with analytically derived insights to support clinician-specific and patient-specific actionability. HealthVision combines state-of-the-art AI/ML and generative AI technologies with scalable cloud computing, delivering a complete suite of predictive models and AI-optimized workflows across the continuum of care. The platform aggregates EHR encounters into a holistic, single-screen risk profile at the patient level, SpotlightTM, transforming the sprawling, less-structured EHR data into normalized knowledge for the entire care team. 

Digital Twinning Optimization 

HDAI’s models are rooted in substantial expertise and research. Building on these models is the process of digital twinning whereby every patient is compared with “twins” who have similar demographics and baseline risk, accounting for regional differences and other factors.  This precise control group adds meaning and context for specific clients and use cases, enabling a deep understanding of patient-, physician-, and population-level performance of utilization, outcomes, and cost intersections without requiring client data. This distinctive approach allows HDAI to profile every individual provider, facility, or organization in the United States, empowering clients with information, tools, and services to optimize network design and construction. 

From Screens to Patients 

One of the most significant impacts of HealthVision is its ability to shift clinicians away from EHR screentime towards patient-focused care optimization. By aggregating data and presenting it in an easily digestible format, HealthVision makes it easier for clinicians to direct their limited time with patients to focus on prevention opportunities and downstream complication avoidance.  

HDAI’s transformative solutions have already made a substantial impact.  The company supports many ACOs, directly managing about 1 million patients and working with innovative health systems across the country including Houston Methodist, Cleveland Clinic and Dana Farber Cancer Institute. By providing unparalleled insights and capabilities, HDAI is paving the way for high-performance healthcare organizations to usher in a new era of patient-centric, data-driven excellence.  

Responsible AI and HDAI 

HDAI has stated that AI models today are not adequate to eliminate informed clinical decision making and the focus should be on how AI technologies can make clinicians more efficient. HDAI is built on the premise of responsible AI use, and is committed to upholding these principles in their work with health systems and hospitals.  

HDAI defines responsible AI in healthcare as being transparent, explainable, traceable, unbiased, and clinician-centric. 

  1. Transparent – HDAI has published our methodology and related research in leading academic journals and posted models publicly.  
  2. Explainable and Traceable – For every risk prediction on the enterprise platform HealthVision, HDAI includes key factors that contribute to each risk prediction and provides clinicians the capability to trace such factors to their source.  
  3. Unbiased – To avoid complex sources of bias, HDAI does not include social drivers of health and race information in AI models. Instead, the company leverages models and digital twinning methodology to detect bias and identify differences in outcomes and performance related to health equity and access. This information can help to identify biases in current practice and help organizations address it in the future.
  4. Clinician-centric – HDAI deploys predictive models with the goal of supporting, never replacing, clinical judgment.


HDAI uses an array of AI tools including Generative AI, where HDAI has built a governance wrapper that ensures the output is explainable, traceable, and verifiable by the clinical user. A lot of learning still needs to happen by all involved, but this approach will ensure HDAI is doing their part to deliver a safe, secure, and trustworthy environment for AI in healthcare.  

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray VP Analytic Services

Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.

Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain Chief Product Officer

David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.

Margie Ahearn

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO

Nassib is a data scientist, lover of logistical regression and a serial entrepreneur. Previously, he was Founder and CEO of Aspect Medical Systems, a Nasdaq traded company now owned by Medtronic. Outside of work, he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture


We are driven to make a profound impact on US healthcare


We operate in the best interests of patients and those who serve them


We understand and protect patient privacy and health information security


We use data science to enhance, but never replace clinical expertise and judgment


We are committed to continuous learning and improvement


We bring rigor, discipline, and reliability to our work


We start with kindness, assuming good intent in others


We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated


We are committed to the well-being of our employees and their families

Our vision

We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, which will improve the health of individuals and populations.

Our mission

Deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.

Who we are

We collaborate with leading health systems and integrated delivery networks, value-based care and accountable care organizations, physician groups, and commercial payers to improve care delivery and population health while reducing costs and making efficient use of scarce clinical resources.

Phil Devlin

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.